C. Scaletta

Discipline

Histoire, Philosophie et Sociologie des sciences (2) Anthropologie biologique (2) Gestion et management (1)

Type de document

Articles (31) Recensions (3) Autres (1)

Co-auteur

Date

Source

Mot-clé

Manufactures (16) Cellular therapy (16) Development (14) tissu (corporel) (12) peau (12) Treatment (12) Skin (12) sécurité (11) Swiss (11) Process (Law) (11) Regenerative medicine (11) gestion (10) Cell transplantation (10) Patients (10) Management (10) Cells (10) Management (10) Patients (10) activité bancaire (9) Human beings (9) Experience (9) Banks and banking (9) Quality (8) régénération (7) survie (7) Regeneration (7) Care (7) Survival (7) Properties (7) Use (7)

Documents écrit par C. Scaletta (31) | parle de C. Scaletta (0)

Mechanistic Insights into the Multiple Functions of Niacinamide: Therapeutic Implications and Cosmeceutical Applications in Functional Skincare Products.
C. Marques et al. (30 mars 2024)
Ex Vivo Functional Benchmarking of Hyaluronan-Based Osteoarthritis Viscosupplement Products: Comprehensive Assessment of Rheological, Lubricative, Adhesive, and Stability Attributes.
A. Porcello et al. (9 oct. 2023)
Autologous and Allogeneic Cytotherapies for Large Knee (Osteo)Chondral Defects: Manufacturing Process Benchmarking and Parallel Functional Qualification.
V. Philippe et al. (16 sept. 2023)
Cutaneous Cell Therapy Manufacturing Timeframe Rationalization: Allogeneic Off-the-Freezer Fibroblasts for Dermo-Epidermal Combined Preparations (DE-FE002-SK2) in Burn Care.
X. Chen et al. (16 sept. 2023)
Bio-Enhanced Neoligaments Graft Bearing FE002 Primary Progenitor Tenocytes: Allogeneic Tissue Engineering & Surgical Proofs-of-Concept for Hand Ligament Regenerative Medicine.
A. Jeannerat et al. (3 juil. 2023)
Industrial Biotechnology Conservation Processes: Similarities with Natural Long-Term Preservation of Biological Organisms.
A. Laurent et al. (31 janv. 2023)
Lyophilized Progenitor Tenocyte Extracts: Sterilizable Cytotherapeutic Derivatives with Antioxidant Properties and Hyaluronan Hydrogel Functionalization Effects.
A. Laurent et al. (10 janv. 2023)
Retrospectives on Three Decades of Safe Clinical Experience with Allogeneic Dermal Progenitor Fibroblasts: High Versatility in Topical Cytotherapeutic Care.
A. Laurent et al. (4 janv. 2023)
Exudative glutamine losses contribute to high needs after burn injury.
M.M. Berger et al.
Retrospective Analysis of Autologous Chondrocyte-Based Cytotherapy Production for Clinical Use: GMP Process-Based Manufacturing Optimization in a Swiss University Hospital.
V. Philippe et al. (17 mars 2022)
Combination of Hyaluronan and Lyophilized Progenitor Cell Derivatives: Stabilization of Functional Hydrogel Products for Therapeutic Management of Tendinous Tissue Disorders.
A. Laurent et al. (19 déc. 2021)
Back to the Cradle of Cytotherapy: Integrating a Century of Clinical Research and Biotechnology-Based Manufacturing for Modern Tissue-Specific Cellular Treatments in Switzerland.
A. Laurent et al. (17 déc. 2021)
Hypoxic Incubation Conditions for Optimized Manufacture of Tenocyte-Based Active Pharmaceutical Ingredients of Homologous Standardized Transplant Products in Tendon Regenerative Medicine.
A. Jeannerat et al. (25 oct. 2021)
Burn Center Organization and Cellular Therapy Integration: Managing Risks and Costs.
M. Chemali et al. (30 sept. 2021)
Corrigendum to: Burn Center Organization and Cellular Therapy Integration: Managing Risks and Costs.
M. Chemali et al. (30 sept. 2021)
Optimized Manufacture of Lyophilized Dermal Fibroblasts for Next-Generation Off-the-Shelf Progenitor Biological Bandages in Topical Post-Burn Regenerative Medicine.
A. Laurent et al. (23 août 2021)
Industrial Development of Standardized Fetal Progenitor Cell Therapy for Tendon Regenerative Medicine: Preliminary Safety in Xenogeneic Transplantation.
A. Grognuz et al. (3 avr. 2021)
Retrospective Evaluation of Progenitor Biological Bandage Use: A Complementary and Safe Therapeutic Management Option for Prevention of Hypertrophic Scarring in Pediatric Burn Care.
L. Deghayli et al. (28 févr. 2021)
Development of Standardized Fetal Progenitor Cell Therapy for Cartilage Regenerative Medicine: Industrial Transposition and Preliminary Safety in Xenogeneic Transplantation.
A. Laurent et al. (9 févr. 2021)
Holistic Approach of Swiss Fetal Progenitor Cell Banking: Optimizing Safe and Sustainable Substrates for Regenerative Medicine and Biotechnology.
A. Laurent et al. (2020)
Cell therapies for skin regeneration: an overview of 40 years of experience in burn units.
M. Michetti et al. (6 mai 2019)
Stability Enhancement Using Hyaluronic Acid Gels for Delivery of Human Fetal Progenitor Tenocytes.
A. Grognuz et al. (3 déc. 2016)
Human Fetal Progenitor Tenocytes for Regenerative Medicine.
A. Grognuz et al. (2016)
Cell Therapy Assistance in Reconstructive Surgery for Musculoskeletal Tissues Following Burn and Trauma: Swiss Cellular Transplantation Platform
A. De Buys Roessingh et al. (2013)
Development of a cost-effective method for platelet-rich plasma (PRP) preparation for topical wound healing.
K. Akhundov et al. (2012)

next